House Committee To Investigate FDA Inaction On CBD Regulation, GOP Chair Warns About Dangers
House Committee on Oversight and Accountability chairman James Comer announced the investigation into the Food and Drug Administration’s (FDA) failure to regulate cannabidiol (CBD) products as dietary supplements.
